Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D P Greenberg

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
The Pediatric Infectious Disease Journal|July 1, 1996
Comparative safety and immunogenicity of two recombinant hepatitis B vaccines given to infants at two, four and six months of ageD P Greenberg, C M Vadheim, V K Wong, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2000
Immunogenicity of a heptavalent pneumococcal conjugate vaccine in Apache and Navajo Indian, Alaska native, and non-native American children aged <2 yearsK M Miernyk, A J Parkinson, K M Rudolph, et al.
Vaccine|January 1, 1993
Anti-PRP antibody levels after a primary series of PRP-OMPC and persistence of antibody titres following primary and booster dosesG B Calandra, L J Lukacs, L C Jonas, et al.
The Journal of Infectious Diseases|August 18, 2001
Antibody responses to bovine parainfluenza virus type 3 (PIV3) vaccination and human PIV3 infection in young infantsM S Lee, D P Greenberg, S H Yeh, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
The Pediatric Infectious Disease Journal|July 1, 1996
Comparative safety and immunogenicity of two recombinant hepatitis B vaccines given to infants at two, four and six months of ageD P Greenberg, C M Vadheim, V K Wong, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2000
Immunogenicity of a heptavalent pneumococcal conjugate vaccine in Apache and Navajo Indian, Alaska native, and non-native American children aged <2 yearsK M Miernyk, A J Parkinson, K M Rudolph, et al.
Vaccine|January 1, 1993
Anti-PRP antibody levels after a primary series of PRP-OMPC and persistence of antibody titres following primary and booster dosesG B Calandra, L J Lukacs, L C Jonas, et al.
The Journal of Infectious Diseases|August 18, 2001
Antibody responses to bovine parainfluenza virus type 3 (PIV3) vaccination and human PIV3 infection in young infantsM S Lee, D P Greenberg, S H Yeh, et al.
Pageof 4